VirtaMed and Medical Microinstruments Partner to Advance the Skills of Surgeons Performing Complex Robotic Microsurgeries

VirtaMed’s VR simulations provide advanced training for surgeons using MMI’s Symani® Robotic System and introduce new product testing capabilities

VirtaMed, a world leader in medical simulation training, and Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, have announced a partnership where surgeons using MMI’s Symani® Surgical System will have access to groundbreaking surgical simulations, leading to advanced skill development and robotic system enhancements.

Microsurgeries are a category of complex surgical procedures that focus on reconstructive surgery and require optical magnification, precision, and dexterity. VirtaMed is developing custom surgical simulations for the Symani System that include aspects of virtual reality (VR) and allow surgeons to train on the system itself. These VR-enabled simulations will allow surgeons to practice a variety of microsurgeries using the Symani robotic system and simulated surgical scenarios.

This will provide MMI and surgeons with a range of benefits including the ability to improve and measure surgical skills in a safe, simulated environment, and access to data-driven insights into surgical approaches that can be used to make enhancements to the Symani System. As robotic microsurgeries continue to grow, opportunities for advanced product development and training are essential to improve patient safety and outcomes.

“Surgeon confidence and patient safety are essential to successful outcomes. This belief has guided our product and partnership approach since the company was formed,” said Stefan Tuchschmid, Co-CEO at VirtaMed. “Our team is excited to partner with MMI, whose microinstruments truly expand human capabilities in microsurgery. By offering surgeons the opportunity to use simulations to practice these highly complex surgeries, we create an environment of continual improvement with a focus on patient care.”

The Symani Surgical System is the only robotic platform dedicated to microsurgery that offers wristed microinstruments designed to improve a surgeon’s ability to suture delicate anatomy, which can be difficult to access. The system combines NanoWrist® Instruments, featuring the world’s smallest robotic wrist, with NanoScale® Technology to scale movements and reduce tremor to push the boundaries of micro and supermicrosurgery. Together, these innovations are intended to increase dexterity and precision, reduce complications and reinterventions, and decrease the learning curve for performing complex microsurgical tasks.

In addition, the integration of VirtaMed simulations into the Symani development process will allow MMI to repeatedly and efficiently test new features and solutions that will optimize the product life cycle.

“We were looking for a portable solution that demonstrates the experience and advantages of Symani while providing a realistic microsurgery training environment,” said Mark Toland, CEO of MMI SpA. “In VirtaMed, we’ve found a partner who shares our mission to improve patient outcomes and the quality

of care through comprehensive training methods, allowing us to enrich the training experiences of our surgeons and drive adoption of robotic microsurgery.”

For more on VirtaMed’s robotic training solutions, visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”